Echocardiographic predictors of symptomatic patent ductus arteriosus in extremely-low-birth-weight preterm neonates

Journal of Perinatology

Volumn 30, Issue 8, 2010, Pages 535-539

  Ramos, F G ^a   Rosenfeld, C R ^a   Roy, L ^b   Koch, J ^a   Ramaciotti, C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

Author keywords

clinically significant patent ductus arteriosus; ductus arteriosus; positive predictive value; pulmonary artery diameter; sensitivity

Indexed keywords

INDOMETACIN;

ARTICLE; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; HEART SURGERY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PERINATAL PERIOD; PULMONARY ARTERY; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION;

DUCTUS ARTERIOSUS, PATENT; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE; PREDICTIVE VALUE OF TESTS; REGIONAL BLOOD FLOW; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 77955174751     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2010.14     Document Type: Article

References (19)

1. Yu VY. Patent ductus arteriosus in the preterm infant. Early Hum Dev 1999; 35: 1-14.
2. Furzan JA, Reisch J, Tyson JE, Laird P, Rosenfeld CR. Incidence and risk factors for symptomatic patent ductus arteriosus among inborn very-low-birth-weight infants. Early Hum Dev 1985; 12: 39-48.
3. Mouzinho AI, Rosenfeld CR, Risser R. Symptomatic patent ductus arteriosus in very-low-birth-weight infants: 1987-1989. Early Hum Dev 1991; 27: 65-77.
4. Ellison RC, Peckham GJ, Lan P, Talner NS, Lerer TJ, Lin L et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 1983; 71: 364-372.
5. Quinn D, Cooper B, Clyman RI. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy. Pediatrics 2002; 110: e10.
6. Reller MD, Lorenz JM, Kotagal UR, Meyer RA, Kaplan S. Hemodynamically significant PDA: an echocardiographic and clinical assessment of incidence, natural history, and outcome in very low birth weight infants maintained in negative fluid balance. Pediatr Cardiol 1985; 6: 17-23.
7. Cotton RB, Lindstrom DP, Stahlman MT. Early prediction of symptomatic patent ductus arteriosus from perinatal risk factors: a discriminant analysis model. Acta Paediatr Scand 1981; 70: 723-727.
8. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol 2006; 26: S14-S18.
9. Laughon ML, Simmons MA, Bose CL. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr 2004; 16: 146-151.
10. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006; 117: 1113-1121.
11. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Eng J Med 2001; 344: 1966-1972.
12. Schmidt B, Roberts RS, Fanaroff A, Davis P, Kirpalani HM, Nwacsei C, et al., TIPP Investigators. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr 2006; 148(6): 730-734.
13. Koehne PS, Bein G, Alexi-Meskhishvili V, Weng Y, Biihrer C, Obladen M. Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. J Perinat Med 2001; 29: 327-334.
14. Constantine NA, Kraemer HC, Kendall-Tackett KA, Bennett FC, Tyson JE, Gross RT. Use of physical and neurologic observations in assessment of gestational age in low birth weight infants. J Pediatr 1987; 110: 921-928.
15. Jimenez JM, Tyson JE, Reisch JS. Clinical measures of gestational age in normal pregnancies. Obstet Gynecol 1983; 61: 438-443.
16. Cotton RB, Stahlman MT, Catterton WZ. Medical management of small preterm infants with symptomatic patent ductus arteriosus. J Pediatr 1978; 92: 467-473.
17. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al., Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
18. Wald RM, Adatia I, Van Arsdell GS, Hornberger LK. Relation of limiting ductal patency to survival in neonatal Ebstein's anomaly. Am J Cardiol 2005; 96: 851-856.
19. Tshuppert S, Doell C, Arlettaz-Mieth R, Baenziger O, Roussson V, Balmer C et al. The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates: size matters. J Thorac Cardiovasc Surg 2008; 135: 78-82.